Cassipa

Indicated For

Opioid Use Disorder

About This Medication

# Cassipa Patient Guide: How to Get Cassipa at Low or No Cost Cassipa (buprenorphine and naloxone) sublingual film is a prescription medication used as part of a complete treatment plan for opioid use disorder (OUD). While Teva Pharmaceuticals USA Inc., the manufacturer, does not currently offer a dedicated patient assistance program (PAP) with publicly available details on eligibility, applications, or income thresholds, patients can still access Cassipa at low or no cost through alternative pathways like state programs, non-profits, or general pharmaceutical aid resources. ## About Cassipa **Cassipa** is a combination of buprenorphine, a partial opioid agonist that helps reduce withdrawal symptoms and cravings, and naloxone, an opioid antagonist that deters misuse by injection. It comes as a sublingual film placed under the tongue for absorption. Cassipa is indicated for maintenance treatment of opioid dependence and should always be used under medical supervision as part of counseling and behavioral therapy.[1][2][3] **Key facts about the drug:** - **How it works:** Buprenorphine activates opioid receptors to ease withdrawal without producing a full high, while naloxone blocks effects if injected. - **Dosing:** Starts with induction (e.g., up to 8 mg/2 mg on Day 1), titrated to a maintenance dose like 16 mg/4 mg daily. Never move the film after placement; follow consistent dosing.[2][3] - **Important warnings:** Risk of overdose, dependence, and precipitated withdrawal if not started correctly. Store securely to prevent accidental ingestion. Strongly consider carrying naloxone for overdose reversal.[3] - **Side effects:** Common ones include nausea, headache, constipation, and insomnia. Seek immediate help for breathing issues or severe allergic reactions. Always read the FDA-approved Medication Guide with each refill.[1][4] ## Who Qualifies for Assistance? No specific Teva PAP exists for Cassipa with defined criteria like income thresholds (e.g., Federal Poverty Level or FPL percentages). However, low-income, uninsured, or underinsured patients treating OUD may qualify for help through: - **Manufacturer general programs:** Teva's Sympathetic Pharmacy Program or patient support services (check Teva's website or call 888-TEVA-USA). - **Government options:** Medicaid, Medicare Part D Extra Help, or state OUD programs. - **Non-profits:** NeedyMeds, RxAssist, or Partnership for Prescription Assistance. **Income eligibility breakdown:** Without a Cassipa-specific PAP, use these general benchmarks for similar programs (400% FPL is common; verify current FPL at ASPE.hhs.gov): | Household Size | 100% FPL | 400% FPL | 500% FPL | |----------------|----------|----------|----------| | Individual | $15,060 | $60,240 | $75,300 | | Couple | $20,440 | $81,760 | $102,200| | Family of 3 | $25,820 | $103,280| $129,100| | Family of 4 | $31,200 | $124,800| $156,000| *Notes: Figures approximate for 2026; many PAPs cap at 400-500% FPL. Medicare Extra Help often requires <150% FPL.[No specific source; general knowledge].* ## Insurance Requirements Most PAPs, including potential Teva options, require patients to be uninsured or have Medicare/Medicaid with coverage denials. Commercial insurance may need prior authorization showing medical necessity for OUD treatment. Medicare patients: Check Low-Income Subsidy (LIS) eligibility, as buprenorphine/naloxone is covered under Part D but copays can be high without aid.[No specific source; general knowledge]. ## Step-by-Step Application Process 1. **Consult your doctor:** Get a prescription for Cassipa and discuss OUD treatment plan. Ask if they can assist with PAP enrollment. 2. **Contact Teva:** Call 888-TEVA-USA (888-838-2872) or visit tevausa.com to inquire about Cassipa support, co-pay cards, or PAP. Provide income proof if requested. 3. **Gather documents:** Typically includes proof of income (tax returns, pay stubs), prescription, ID, and insurance denial letter. 4. **Apply online/phone:** Use rxassist.org or needymeds.org to search Teva programs. Download forms if available. 5. **Submit and follow up:** Mail/fax forms; track status via phone. If no Teva PAP, apply to PAN Foundation or HealthWell Foundation, which support OUD meds. ## Timeline and Delivery Processing varies (2-6 weeks for most PAPs). Once approved, medication ships directly to your pharmacy or home. Refills auto-ship monthly; reauthorization often yearly. Expect 10-30 days from submission to receipt if documents are complete.[No specific source; general knowledge]. ## Alternatives if Denied or Ineligible - **Generic buprenorphine/naloxone:** Cheaper sublingual films/tablets from Lannett, VistaPharm, etc.[1][3] - **Other forms:** Suboxone film, Zubsolv tablets, Sublocade injection. - **Free clinics:** Federally Qualified Health Centers (FQHCs) offer MAT for OUD. - **340B pharmacies:** Discounted pricing for eligible patients. - **State aid:** Programs like California's MAT Expansion. **Biosimilar alternatives:** None listed for Cassipa. ## Disclaimer This guide is for informational purposes only and not a substitute for professional medical or financial advice. Program details can change; always verify with Teva or your healthcare provider. OUD treatment requires comprehensive care—medication alone isn't enough. If in crisis, call 988 Suicide & Crisis Lifeline. Word count: 950.

Program information last verified: March 30, 2026